The study aims to understand the attitudes of patients and health professionals (pathologists and oncologists) regarding the use of using spatial sequencing technology for diagnosing non-small cell lung cancer (NSCLC).
Through this exploration, the project aims to uncover both opportunities and challenges associated with this innovative approach.
The insights gained will aid in the development of strategies to address potential barriers and will support the ongoing effectiveness and beta testing of the technology at the Futures Institute. Understanding the attitudes of patients and health professionals towards spatial sequencing in the diagnosis of NSCLC is crucial for guiding the potential adoption of this technology to support future care for patients.
